Anders Sundström

Socioeconomic factors associated with poor medication adherence in patients with type 2 diabetes

Ekenberg, Marie; Qvarnström, Miriam; Sundström, Anders; Martinell, Mats et al.

Part of European Journal of Clinical Pharmacology, p. 53-63, 2024

• DOI for Socioeconomic factors associated with poor medication adherence in patients with type 2 diabetes
• Download full text (pdf) of Socioeconomic factors associated with poor medication adherence in patients with type 2 diabetes

ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors

Mainwaring, Oliver; Weishaupt, Holger; Zhao, Miao; Rosén, Gabriela et al.

Part of Nature Communications, 2023

• DOI for ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors
• Download full text (pdf) of ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors

Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma

Borgenvik, Anna; Holmberg, Karl O.; Bolin, Sara; Zhao, Miao et al.

Part of Cancer Research, p. 4586-4603, 2022

• DOI for Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
• Download full text (pdf) of Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma

Post-stroke epilepsy and antiepileptic drug use in men and women

Loikas, Desiree; Linner, Love; Sundström, Anders; Wettermark, Björn et al.

Part of Basic & Clinical Pharmacology & Toxicology, p. 148-157, 2021

• DOI for Post-stroke epilepsy and antiepileptic drug use in men and women
• Download full text (pdf) of Post-stroke epilepsy and antiepileptic drug use in men and women

SOX9 Defines Distinct Populations of Cells in SHH Medulloblastoma but Is Not Required for Math1-Driven Tumor Formation

Adolphe, Christelle; Millar, Amanda; Kojic, Marija; Barkauskas, Deborah S. et al.

Part of Molecular Cancer Research, p. 1831-1839, 2021

• DOI for SOX9 Defines Distinct Populations of Cells in SHH Medulloblastoma but Is Not Required for Math1-Driven Tumor Formation

Socioeconomic factors associated with poor medication adherence in patients with type 2 diabetes

Ekenberg, Marie; Qvarnström, Miriam; Sundström, Anders; Martinell, Mats et al.

Part of European Journal of Clinical Pharmacology, p. 53-63, 2024

• DOI for Socioeconomic factors associated with poor medication adherence in patients with type 2 diabetes
• Download full text (pdf) of Socioeconomic factors associated with poor medication adherence in patients with type 2 diabetes

ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors

Mainwaring, Oliver; Weishaupt, Holger; Zhao, Miao; Rosén, Gabriela et al.

Part of Nature Communications, 2023

• DOI for ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors
• Download full text (pdf) of ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors

Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma

Borgenvik, Anna; Holmberg, Karl O.; Bolin, Sara; Zhao, Miao et al.

Part of Cancer Research, p. 4586-4603, 2022

• DOI for Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
• Download full text (pdf) of Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma

Post-stroke epilepsy and antiepileptic drug use in men and women

Loikas, Desiree; Linner, Love; Sundström, Anders; Wettermark, Björn et al.

Part of Basic & Clinical Pharmacology & Toxicology, p. 148-157, 2021

• DOI for Post-stroke epilepsy and antiepileptic drug use in men and women
• Download full text (pdf) of Post-stroke epilepsy and antiepileptic drug use in men and women

SOX9 Defines Distinct Populations of Cells in SHH Medulloblastoma but Is Not Required for Math1-Driven Tumor Formation

Adolphe, Christelle; Millar, Amanda; Kojic, Marija; Barkauskas, Deborah S. et al.

Part of Molecular Cancer Research, p. 1831-1839, 2021

• DOI for SOX9 Defines Distinct Populations of Cells in SHH Medulloblastoma but Is Not Required for Math1-Driven Tumor Formation

Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma

Simonds, Erin F.; Lu, Edbert D.; Badillo, Oscar; Karimi, Shokoufeh et al.

Part of Journal for ImmunoTherapy of Cancer, 2021

• DOI for Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma
• Download full text (pdf) of Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma

Integrative discovery of treatments for high-risk neuroblastoma

Almstedt, Elin; Elgendy, Ramy; Hekmati, Neda; Rosén, Emil et al.

Part of Nature Communications, 2020

• DOI for Integrative discovery of treatments for high-risk neuroblastoma
• Download full text (pdf) of Integrative discovery of treatments for high-risk neuroblastoma

A molecularly distinct subset of glioblastoma requires serum-containing media to establish sustainable bona fide glioblastoma stem cell cultures

Maturi, Naga Prathyusha; Tan, E-Jean; Xie, Yuan; Sundström, Anders et al.

Part of Glia, p. 1228-1240, 2020

• DOI for A molecularly distinct subset of glioblastoma requires serum-containing media to establish sustainable bona fide glioblastoma stem cell cultures

Modeling SHH-driven medulloblastoma with patient iPS cell-derived neural stem cells

Susanto, Evelyn; Navarro, Ana Marin; Zhou, Leilei; Sundström, Anders et al.

Part of Proceedings of the National Academy of Sciences of the United States of America, p. 20127-20138, 2020

• DOI for Modeling SHH-driven medulloblastoma with patient iPS cell-derived neural stem cells
• Download full text (pdf) of Modeling SHH-driven medulloblastoma with patient iPS cell-derived neural stem cells

LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients

Xie, Yuan; Sundström, Anders; Maturi, Naga P; Tan, E-Jean et al.

Part of Journal of Pathology, p. 228-240, 2019

• DOI for LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients

Batch-normalization of cerebellar and medulloblastoma gene expression datasets utilizing empirically defined negative control genes

Weishaupt, Holger; Johansson, Patrik; Sundström, Anders; Lubovac-Pilav, Zelmina et al.

Part of Bioinformatics, p. 3357-3364, 2019

• DOI for Batch-normalization of cerebellar and medulloblastoma gene expression datasets utilizing empirically defined negative control genes
• Download full text (pdf) of Batch-normalization of cerebellar and medulloblastoma gene expression datasets utilizing empirically defined negative control genes

Mesenchymal transition and increased therapy resistance of glioblastoma cells is related to astrocyte reactivity

Niklasson, Mia; Bergström, Tobias; Jarvius, Malin; Sundström, Anders et al.

Part of Journal of Pathology, p. 295-307, 2019

• DOI for Mesenchymal transition and increased therapy resistance of glioblastoma cells is related to astrocyte reactivity

Humanized Stem Cell Models of Pediatric Medulloblastoma Reveal an Oct4/mTOR Axis that Promotes Malignancy

Čančer, Matko; Hutter, Sonja; Holmberg Olausson, Karl; Rosén, Gabriela et al.

Part of Cell Stem Cell, p. 855-870, 2019

• DOI for Humanized Stem Cell Models of Pediatric Medulloblastoma Reveal an Oct4/mTOR Axis that Promotes Malignancy
• Download full text (pdf) of Humanized Stem Cell Models of Pediatric Medulloblastoma Reveal an Oct4/mTOR Axis that Promotes Malignancy

Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma

Bolin, Sara; Borgenvik, Anna; Persson, Camilla U.; Sundström, Anders et al.

Part of Oncogene, p. 2850-2862, 2018

• DOI for Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma
• Download full text (pdf) of Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma

Mouse models of pediatric supratentorial high-grade glioma reveal how cell-of-origin influences tumor development and phenotype

Sreedharan, Smitha; Maturi, Naga Prathyusha; Xie, Yuan; Sundström, Anders et al.

Part of Cancer Research, p. 802-812, 2017

• DOI for Mouse models of pediatric supratentorial high-grade glioma reveal how cell-of-origin influences tumor development and phenotype

FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma

Rahmanto, Aldwin Suryo; Savov, Vasil; Brunner, Andrä; Bolin, Sara et al.

Part of EMBO Journal, p. 2192-2212, 2016

• DOI for FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma
• Download full text (pdf) of FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma

Photoreceptor-positive cells of tumor origin in MYC-driven Group 3 medulloblastoma

Zhao, Miao; Mainwaring, Oliver; Rosén, Gabriela; Rijpkema, Sanne et al.

Prioritization of candidate cancer genes on chromosome 17q through reverse engineered transcriptional regulatory networks in medulloblastoma groups 3 and 4

Weishaupt, Holger; Johansson, Patrik; Mainwaring, Oliver; Hutter, Sonja et al.

Paired glioblastoma cell cultures of the fluorescent bulk tumor and non-fluorescent tumor margin display differential phenotypes and cell states across patients

Neves, Inês; Lu, Xi; Maturi, Nagaprathyusha; Dang, Yonglong et al.